These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4020358)

  • 1. Bronchogenic carcinoma and hypercalcemia.
    Lueg MC; Barkman HW
    J La State Med Soc; 1985 May; 137(5):66-70. PubMed ID: 4020358
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcemia in bronchogenic carcinoma.
    Shankar PS
    J Assoc Physicians India; 1979 Jan; 27(1):19-25. PubMed ID: 511820
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum calcium in bronchial carcinoma: a population-based study.
    Gislason T; Palmér M; Nõu E
    Eur J Respir Dis; 1987 Jan; 70(1):8-13. PubMed ID: 3817068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
    Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
    Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum hCG in bronchogenic carcinoma.
    Behera D; Dash S; Malik SK; Dash RJ
    Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta-2-microglobulin in bronchogenic carcinoma].
    Zatloukal P; Dudková V; Mĕricka O
    Sb Lek; 1990; 92(11-12):366-9. PubMed ID: 2136432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood lactate threshold in patients with bronchogenic carcinoma].
    Miyoshi S; Monden Y; Nakahara K; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Kido T; Maeda H; Ikeda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun; 24(6):618-24. PubMed ID: 3773366
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful combination chemotherapy for metastatic parathyroid carcinoma.
    Bukowski RM; Sheeler L; Cunningham J; Esselstyn C
    Arch Intern Med; 1984 Feb; 144(2):399-400. PubMed ID: 6696578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia and bronchial carcinoma.
    CAREY VC
    Am Rev Respir Dis; 1962 Feb; 85():258-60. PubMed ID: 13876568
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercalcemia in lithium therapy--an underestimated complication?].
    Kallner G; Lindelius R; Markiewicz P; Mathé A; Pettersson U; Nilsson CG
    Lakartidningen; 1992 Nov; 89(48):4163-4. PubMed ID: 1461037
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hexosamine and its correlations with serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Kokkola K; Tani P
    Scand J Respir Dis Suppl; 1972; 80():137-41. PubMed ID: 4510910
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():121-8. PubMed ID: 4510909
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
    Robertson RP; Baylink DJ; Marini BJ; Adkison HW
    J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening and transcortin binding capacity of ectopic ACTH producing lung cancer].
    Kusama M; Abe O; Sakauchi N; Kumaoka S; Ishikawa S
    Gan No Rinsho; 1969 Oct; 15(10):859-65. PubMed ID: 4310775
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
    Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
    Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
    [No Abstract]   [Full Text] [Related]  

  • 19. Parathyroid hormone measurements in hyperparathyroidism and hypercalcemia due to nonparathyroid cancers.
    Lohrenz FN
    Wis Med J; 1971 Jun; 70(6):159-61. PubMed ID: 5561285
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some biochemical possibilities for early bronchogenic carcinoma diagnosis].
    Procházka J; Kopecký P; Deyl Z; Svojtková E; Smíd A; Burian I
    Cas Lek Cesk; 1976 Oct; 115(41):1262-5. PubMed ID: 991175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.